Adolore BioTherapeutics, Inc., (”Adolore” or the “Company”), a biotechnology company developing transformational opioid-free intracellularly-delivered treatments for chronic pain, today announced that ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free intracellularly-delive ...
according to the R.I. Department of Health Prescription Drug Monitoring Program. This is despite a series of pain studies that have shown, in most cases, that non-opioid alternatives such as a ...
Drug overdose is the leading cause of injury ... He is the medical director of the opioid treatment program at We Care Daily Clinics in Auburn, Wash. "Ketamine, at an imperceptibly low dose ...